|
Markt geschlossen -
Sao Paulo
21:38:04 11.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 43.71 BRL | -12.14% |
|
-5.70% | -23.80% |
| 08.09. | Abbott erhält FDA-Zulassung für TactiFlex Duo-Ablationskatheter zur Behandlung von Herzrhythmusstörungen | CI |
| 08.09. | Abbott Laboratories erhält FDA-Zulassung für Dual-Energy-AFib-Katheter | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.36% | -5.89% | -8.38% | +15.62% | -18.63% | -23.76% | -0.72% | -19.48% | +150.86% | 176 Mrd. | |
| -0.72% | -3.41% | +0.42% | +13.42% | -5.31% | -3.26% | +11.85% | -30.05% | +7.21% | 116 Mrd. | |
| +0.19% | -2.83% | +3.73% | +14.17% | -4.79% | +6.30% | +82.00% | +160.09% | +277.21% | 61.36 Mrd. | |
| -1.15% | -7.06% | -15.78% | -15.73% | -5.26% | +3.58% | +37.16% | +15.79% | +459.88% | 49.42 Mrd. | |
| +0.81% | -3.73% | -2.26% | +21.62% | -8.36% | -4.81% | -32.89% | -31.23% | +3.95% | 48.44 Mrd. | |
| -1.75% | -5.54% | -9.24% | +10.16% | +25.10% | +8.93% | -21.09% | -38.55% | +261.47% | 31.33 Mrd. | |
| +0.43% | -11.10% | -8.57% | -11.14% | -22.55% | - | - | - | - | 28.54 Mrd. | |
| +0.58% | +1.84% | +0.02% | +5.29% | +25.84% | +36.58% | -12.41% | -21.70% | +331.98% | 24.37 Mrd. | |
| +1.25% | -4.09% | -14.82% | +1.77% | +0.29% | -9.68% | +4.96% | -13.36% | +130.24% | 21.57 Mrd. | |
| +0.32% | -1.79% | +3.15% | +6.44% | -11.00% | +10.17% | -24.61% | -64.40% | +193.22% | 21.11 Mrd. | |
| -0.80% | -6.16% | -10.72% | +1.54% | -16.87% | -15.66% | -8.54% | +0.27% | +201.00% | 20.55 Mrd. | |
| +1.14% | -4.67% | -6.11% | +5.55% | +3.97% | -9.30% | -22.50% | -33.70% | -24.31% | 17.83 Mrd. | |
| -0.23% | -4.62% | +1.15% | +10.88% | +10.36% | +19.16% | - | - | - | 14.89 Mrd. | |
| -1.82% | -3.77% | +0.82% | +9.38% | +14.30% | +13.55% | +98.39% | +32.00% | +342.56% | 14.74 Mrd. | |
| -1.57% | -7.86% | -12.01% | +14.09% | +24.54% | -0.79% | -39.15% | -70.48% | -47.55% | 12.3 Mrd. | |
| +0.07% | -4.93% | -14.40% | -13.74% | -3.41% | +14.64% | -53.22% | -78.78% | +63.97% | 10.71 Mrd. | |
| -0.47% | -1.07% | - | - | - | - | - | - | - | 10.02 Mrd. | |
| +0.86% | -5.24% | -13.67% | -7.71% | -15.03% | +26.30% | +51.10% | -7.92% | +227.55% | 9.96 Mrd. | |
| +0.15% | -4.35% | +2.25% | +29.16% | +21.89% | +31.74% | +0.20% | -53.37% | +135.37% | 9.85 Mrd. | |
| Durchschnitt | -0.21% | -4.61% | -5.80% | +6.15% | +0.84% | +6.10% | +4.41% | -15.93% | +169.66% | 36.83 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.51% | -4.73% | -5.21% | +9.32% | -5.65% | -3.55% | +8.49% | -5.67% | +159.36% |
- Börse
- Aktien
- 850103 Aktie
- ABTT34 Aktie
- Sektor Abbott Laboratories
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
